Focus: RoslinCT is a UK-based biotechnology company specializing in stem cell research and cell therapy development, operating as a public entity since 2006. The company focuses on translating stem cell science into clinical therapies.
Profile data last refreshed 1h ago · AI intelligence enriched 3w ago
RoslinCT is a niche, science-focused biotech with deep stem cell expertise but weak near-term clinical visibility and limited hiring momentum—suitable only for researchers prioritizing scientific depth over career growth acceleration.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for RoslinCT
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from RoslinCT's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company